SCOPUS 정보 검색 플랫폼

Leukemia and Lymphoma

Volumn 54, Issue 7, 2013, Pages 1349-1350

Extramedullary multiple myeloma: Extraosseous relapse is extra bad news, but why?

(2) Moreau, Philippe a Polliack, Aaron b

a UNIVERSITÉ DE NANTES (France)

b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RECURRENCE; EXTRAMEDULLARY RELAPSE; HUMAN; MAINTENANCE THERAPY; MULTIPLE MYELOMA; MYELOMA CELL; NOTE; PRIORITY JOURNAL;

FEMALE; HUMANS; MALE; MULTIPLE MYELOMA; PLASMACYTOMA;

EID: 84879354455 PISSN: 10428194 EISSN: 10292403 Source Type: Journal
DOI: 10.3109/10428194.2012.753451 Document Type: Note

Times cited : (5)

References (11)

1
- 80053621178
- Soft-tissue plasmacytomas in multiple myeloma: Incidence mechanisms of extramedullary spread and treatment approach
- Blade J, Fernández de Larrea C, Rosi ñ ol L, et al. Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach. J Clin Oncol 2011;29 : 3805-3812.
- (2011) J Clin Oncol , vol.29 , pp. 3805-3812
- Blade, J.¹ Fernández De Larrea, C.² RosiOlñ, L.³

2
- 76949137165
- Extramedullary lesions in multiple myeloma; Review of literature and pathologic studies
- Hayes DW, Bennett WA, Heck FJ. Extramedullary lesions in multiple myeloma; review of literature and pathologic studies. AMA Arch Pathol 1952;53:262-272.
- (1952) AMA Arch Pathol , vol.53 , pp. 262-272
- Hayes, D.W.¹ Bennett, W.A.² Heck, F.J.³

3
- 84879389318
- Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting extramedullary relapse
- Papanikolaou X, Repousis P, Tzenou T, et al. Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting extramedullary relapse. Leuk Lymphoma 2013 ; 54:1459-1464.
- (2013) Leuk Lymphoma , vol.54 , pp. 1459-1464
- Papanikolaou, X.¹ Repousis, P.² Tzenou, T.³

4
- 77951882321
- Incidence presenting features and outcome of extramedullary disease in multiple myeloma: A longitudinal study on 1003 consecutive patients
- Varettoni M, Corso A, Pica G, et al. Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients. Ann Oncol 2010 ; 21:325-330.
- (2010) Ann Oncol , vol.21 , pp. 325-330
- Varettoni, M.¹ Corso, A.² Pica, G.³

5
- 61349195971
- The impact of extramedullary disease at presentation in the outcome of myeloma
- Wu P, Davies F, Boyd K, et al. The impact of extramedullary disease at presentation in the outcome of myeloma. Leuk Lymphoma 2009; 50: 230-235.
- (2009) Leuk Lymphoma , vol.50 , pp. 230-235
- Wu, P.¹ Davies, F.² Boyd, K.³

6
- 33644499817
- Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients [14]
- DOI 10.1038/sj.leu.2404085, PII 2404085
- P é rez-Sim ó n JA, Sureda A, Fern á ndez-Aviles F, et al. Reducedintensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients. Leukemia 2006;20:542-545. (Pubitemid 43291766)
- (2006) Leukemia , vol.20 , Issue.3 , pp. 542-545
- Perez-Simon, J.A.¹ Sureda, A.² Fernandez-Aviles, F.³ Sampol, A.⁴ Cabrera, J.R.⁵ Caballero, D.⁶ Martino, R.⁷ Petit, J.⁸ Tomas, J.F.⁹ Moraleda, J.M.¹⁰ Alegre, A.¹¹ Canizo, C.¹² Brunet, S.¹³ Rosinol, L.¹⁴ Lahuerta, J.¹⁵ Diez-Martin, J.L.¹⁶ Leon, A.¹⁷ Garcia, A.¹⁸ Vazquez, L.¹⁹ Sierra, J.²⁰ San Miguel, J.F.²¹ more..

7
- 84861532638
- Clonal competition with alternating dominance in multiple myeloma
- Keats J J, Chesi M, Egan J B, et al. Clonal competition with alternating dominance in multiple myeloma. Blood 2012;120 : 1067-1076.
- (2012) Blood , vol.120 , pp. 1067-1076
- Keats, J.J.¹ Chesi, M.² Egan, J.B.³

8
- 84873565928
- Minor clone provides a reservoir for relapse in multiple myeloma
- M agrangeas F, A vet-Loiseau H, G ouraud W, et al. Minor clone provides a reservoir for relapse in multiple myeloma. Leukemia 2013 ;27:473-481.
- (2013) Leukemia , vol.27 , pp. 473-481
- Magrangeas, F.¹ Avet-Loiseau, H.² Gouraud, W.³

9
- 3242763046
- Extramedullary multiple myeloma escapes the effect of thalidomide
- Rosinol L, Cibeira MT, Blade J, et al. Extramedullary multiple myeloma escapes the eff ect of thalidomide. Haematologica 2004 ; 89:832-836. (Pubitemid 38981343)
- (2004) Haematologica , vol.89 , Issue.7 , pp. 832-836
- Rosinol, L.¹ Cibeira, M.T.² Blade, J.³ Esteve, J.⁴ Aymerich, M.⁵ Rozman, M.⁶ Segarra, M.⁷ Cid, M.C.⁸ Filella, X.⁹ Montserrat, E.¹⁰

10
- 14344262210
- Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloabiatlve allogeneic transplantation
- P atriarca F, P rosdocimo S, T omadini V, et al. Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation. Haematologica 2005; 90:278-279. (Pubitemid 40293302)
- (2005) Haematologica , vol.90 , Issue.2 , pp. 278-279
- Patriarca, F.¹ Prosdocimo, S.² Tomadini, V.³ Vasciaveo, A.⁴ Bruno, B.⁵ Fanin, R.⁶

11
- 26944474502
- Complete remission with bortezomib on plasmacytomas in an end-stage patient with refractory myeloma who failed all other therapies including hematopoietic stem cell transplantation.Possible enhancement of graft-vs-tumor eff ect
- Paubelle E, Coppo P, Garderet L, et al. Complete remission with bortezomib on plasmacytomas in an end-stage patient with refractory myeloma who failed all other therapies including hematopoietic stem cell transplantation. Possible enhancement of graft-vs-tumor eff ect. Leukemia 2005; 19: 702-704.
- (2005) Leukemia , vol.19 , pp. 702-704
- Paubelle, E.¹ Coppo, P.² Garderet, L.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.